Simvastatin Efficacy on Endodontic Biofilms: An In Vitro Study
Metadatos
Mostrar el registro completo del ítemEditorial
MDPI
Materia
antimicrobial biofilm diclofenac
Fecha
2024-11-07Referencia bibliográfica
Ferrer Luque, C.M. et. al. Materials 2024, 17, 5441. [https://doi.org/10.3390/ma17225441]
Patrocinador
Research Group CTS-167 of the Junta de Andalucía, SpainResumen
The outcome of endodontic therapy is directly related to the control of infection. The aim of
the study was to evaluate in vitro the efficacy of Simvastatin (SIM) and diclofenac (DC) solutions on
endodontic biofilms. Methods: Mature biofilms were grown on dentin specimens and put in contact
with the solutions to determine their antibiofilm activity. To assess residual antimicrobial activity, the
dentin samples were immersed for 5 min in the solutions before microbial infection for 3 weeks. The
study groups were: (1) 8% SIM, (2) 4% SIM, (3) 4% DC, (4) 2.5% sodium hypochlorite (NaOCl), and
(5) 0.9% saline solution (SS). Cell viability was evaluated by means of the adenosine triphosphate
(ATP) assay and flow cytometry (FC). The data collected were analyzed with the ANOVA test using
Welch’s correction followed by the Games–Howell test. The level of statistical significance was
p < 0.05, and statistical analysis was performed using SPSS 23.0. Results: All study groups reduced
the biofilms significantly with respect to the control. The highest reduction percentage was obtained
by 2.5% NaOCl, followed by SIM 8% and 4%, without statistically significant differences. In terms
of residual activity, the 4% DC solution obtained a higher percentage of dead cells. Conclusion:
Solutions of 4% and 8% SIM, and 4% Diclofenac, show antimicrobial and residual activity against
multispecies endodontic biofilms.